You are here
- Home
Media
Here you will find our corporate press releases, details on upcoming events and other useful information for business and financial media
-
Latest news expand
Financial results collapse
Second quarter and half year results 2010 announced Thursday, 29 July 2010.
-
Key Facts collapse
- AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.
- We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Read more about our medicines.
- We employ over 62,000 people (47% in Europe, 31% in the Americas and 22% in Asia, Africa and Australasia). Read more about our employees and our culture.
Research & Development collapse
We focus our research on six disease areas where we believe our skills and experience can make the most difference.
Not signed in
Page tools
Share price
- London
-
33.21 GBP - New York
-
51.26 USD - Stockholm
-
376.10 SEK
At 09-Sep-2010 08:28 GMT
Detailed share price